CLINICAL_TRIALS
research
· 2025-11-19
Clinical Trial Update: Scalp Cooling in MBC [Phase 2]
Summary
Phase 2 clinical trial from Dana-Farber Cancer Institute evaluating scalp cooling to prevent chemotherapy-induced alopecia in patients with metastatic breast ca…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Metastatic Breast Cancer, Chemotherapy-induced Alopecia | Phase 2 | Status: RECRUITING